Skip to main content

Business Center

The Administration for Strategic Preparedness and Response (ASPR) collaborates with businesses, organizations, and innovators to enhance the nation's health security. Whether you're interested in contracting opportunities, grants, or partnerships, these resources will help provide opportunities to work with us. Explore how you can contribute to emergency preparedness, response, and resilience efforts. 

Opportunities for SAM.gov
BARDA seeks late-stage clinical development, regulatory approval for 2-PAM autoinjectors (as a drug/device combination product) to treat organophos...
75A50126R00002 BARDA - ASPR / DAAPPO / BARDA DCMA
July 8, 2026 12:00 AM EDT July 30, 2026 5:00 PM EDT
This RFQ is issued as a Total Business Set-Aside. See details and specifications attached...
75A50326Q00018 ASPR/ORM-SNS
July 6, 2026 12:00 AM EDT July 9, 2026 12:00 PM EDT
The BARDA CBRN Division, Chemical MCM Program seeks input from industry, academia, and other stakeholders regarding transformative approaches that...
REDD BARDA - ASPR / DAAPPO / BARDA DCMA
June 29, 2026 12:00 AM EDT July 23, 2026 1:00 PM EDT
Amoxicillin trihydrate 500mg, 60 and 100 ct Oral Capsules...
75A50326F80004-Justification ASPR/ORM-SNS
June 26, 2026 12:00 AM EDT No disponible
UPDATE: Question and Answers attached in documents. Date for submission revised to July 2, 2026. The Office of Biomedical Advanced Research...
RRPV-26-13-BundiVx BARDA - ASPR / DAAPPO / BARDA DCMA
June 18, 2026 12:00 AM EDT July 2, 2026 1:00 PM EDT
“High Performance Antigen Diagnostics” Request for Information (RFI) Purpose The Rapid Response Partnership Vehicle (RRPV) is issuing t...
RRPV-HPAD ASPR BARDA DIV CONTRACTS MGMT & ACQ
June 17, 2026 12:00 AM EDT July 17, 2026 1:00 PM EDT
“ Protection Before Day One Vaccine: Seasonal Influenza Vaccines with Pandemic Coverage ”...
RFI-26-08-PBD1 BARDA - ASPR / DAAPPO / BARDA DCMA
June 3, 2026 12:00 AM EDT July 15, 2026 1:00 PM EDT
AI-Enabled Discovery of Broad-Spectrum Small-Molecule Inhibitors for Filoviruses Purpose: The purpose of this Request for Information...
RRPV-AVAT_PATH-SM BARDA - ASPR / DAAPPO / BARDA DCMA
May 21, 2026 12:00 AM EDT July 17, 2026 1:00 PM EDT
We appreciate your interest in partnering with BARDA. The latest BARDA Broad Agency Announcement (BAA) is Amendment 7 posted on March 19, 2...
BAA-23-100-SOL-00004 BARDA - ASPR / DAAPPO / BARDA DCMA
March 20, 2026 12:00 AM EDT September 25, 2028 4:30 PM EDT
This announcement serves as a reissuance of the BARDA DRIVe EZ-BAA, now known as EZ-BAA-22-100-SOL-00003. This announcement hereby supersedes and r...
DRIVeEZBAA22100SOL00003 BARDA - ASPR / DAAPPO / BARDA DCMA
April 22, 2025 12:00 AM EDT October 18, 2027 4:30 PM EDT
Contract Number: Contract Number: 75A50124C00029 Awarded: 9/27/2024 Contracting Office ZIP Code: Falls Church, VA 220426505...
75A50124C00029 BARDA - ASPR / DAAPPO / BARDA DCMA
September 27, 2024 12:00 AM EDT No disponible

More Ways to do Business with ASPR

BARDA Digital Resources

Visit BARDA’s Stakeholder Portal to engage with BARDA via TechWatch Meeting Request.

BARDA Ventures

BARDA Ventures investment to catalyze health security innovation on a global scale.

Partnering with BARDA

Learn about BARDA’s funding and partnering opportunities including BAA and EZ-BAA.

BioMaP Consortium

Strengthening and enhancing domestic biopharmaceutical manufacturing capabilities.

EQUIP-A-Pharma

Program aims to help develop regulatory approval framework for rapid synthesis and manufacturing of drug products.

IBx Connect

Connecting industry and ASPR to bolster resiliency across the entire public health and medical industrial base.

Linked In Logo

Connect with ASPR on LinkedIn

Did you know ASPR is on LinkedIn? Connect with ASPR on LinkedIn Today!